ACIU•benzinga•
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Summary
AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early Parkinson's disease.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 14, 2024 by benzinga